Skip to main content
SpringerLink
Log in

Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ

  • Chapter
  • First Online:
A Comprehensive Guide to Core Needle Biopsies of the Breast

  • 1454 Accesses

Abstract

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) are lobular intraepithelial neoplasms that are often grouped under the term lobular neoplasia (LN). The pathognomonic feature of LN is discohesion secondary to absence or dysfunction of E-cadherin. LN is divided into classical and variant types and is considered to be both a risk factor and non-obligate precursor of invasive carcinoma. Classical LN is more common, shows indolent behavior, and is managed conservatively. Variant LN includes pleomorphic LCIS and florid LCIS, both of which have examples that would fall under the general category of “LCIS with necrosis.” Variant LN is uncommon and under recognized. Clinical data on variant LN is lacking, however the histology, biomarker profile, molecular alterations, and disease associations suggest a more aggressive disease than classical LN. Currently, there is no clear consensus on management of classical LN when diagnosed on core biopsy, whereas excision is recommended routinely for LN variants.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42(2):737–69.

    Article  CAS  PubMed  Google Scholar 

  2. Hajdu SI, Tang P. Lobular carcinoma in situ. Ann Clin Lab Sci. 2009;39(4):413–5.

    PubMed  Google Scholar 

  3. Ewing J. Neoplastic diseases, a text-book on tumors. Philadelphia: W.B. Saunders Company; 1919.

    Google Scholar 

  4. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17(4):491–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Wheeler JE, Enterline HT, Roseman JM, Tomasulo JP, McIlvaine CH, Fitts Jr WT, et al. Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974;34(3):554–63.

    Article  CAS  PubMed  Google Scholar 

  6. Andersen JA. Lobular carcinoma in situ. A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand Sect Pathol. 1974;82(4):519–33.

    CAS  Google Scholar 

  7. Page DL, Kidd Jr TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22(12):1232–9.

    Article  CAS  PubMed  Google Scholar 

  8. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004;231(3):813–9.

    Article  PubMed  Google Scholar 

  9. Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy—clinical significance. Cancer. 2004;101(2):242–50.

    Article  PubMed  Google Scholar 

  10. Margenthaler JA, Duke D, Monsees BS, Barton PT, Clark C, Dietz JR. Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Am J Surg. 2006;192(4):534–7.

    Article  PubMed  Google Scholar 

  11. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 2006;187(4):949–54.

    Article  PubMed  Google Scholar 

  12. Menon S, Porter GJ, Evans AJ, Ellis IO, Elston CW, Hodi Z, et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch. 2008;452(5):473–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cangiarella J, Guth A, Axelrod D, Darvishian F, Singh B, Simsir A, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med. 2008;132(6):979–83.

    PubMed  Google Scholar 

  14. Destounis SV, Murphy PF, Seifert PJ, Somerville PA, Arieno AL, Morgan RC, et al. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR Am J Roentgenol. 2012;198(2):281–7.

    Article  PubMed  Google Scholar 

  15. Ibrahim N, Bessissow A, Lalonde L, Mesurolle B, Trop I, Lisbona A, et al. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? AJR Am J Roentgenol. 2012;198(2):288–91.

    Article  PubMed  Google Scholar 

  16. Niell B, Specht M, Gerade B, Rafferty E. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR Am J Roentgenol. 2012;199(4):929–35.

    Article  PubMed  Google Scholar 

  17. Meroni S, Bozzini AC, Pruneri G, Moscovici OC, Maisonneuve P, Menna S, et al. Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy. Eur Radiol. 2014;24(7):1651–8.

    Article  PubMed  Google Scholar 

  18. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun Jr DW. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2(3):225–51.

    Article  CAS  PubMed  Google Scholar 

  19. Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004. Cancer epidemiol Biomarkers Prev. 2009;18(6):1763–9.

    Article  PubMed  Google Scholar 

  20. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008–11.

    Article  PubMed  Google Scholar 

  21. Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 2002;75(3):259–68.

    Article  PubMed  Google Scholar 

  22. Wellings SR, Jensen HM. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst. 1973;50(5):1111–8.

    CAS  PubMed  Google Scholar 

  23. Foote FW, Stewart FW. Comparative studies of cancerous versus noncancerous breasts. Ann Surg. 1945;121(1):6–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698–708.

    Article  CAS  PubMed  Google Scholar 

  25. Ellis IO, Programmes NHSCS, Royal College of P. Pathology reporting of breast disease : a joint document incorporating the third edition of the NHS Breast Screening Programme’s Guidelines for pathology reporting in breast cancer screening and the second edition of the Royal College of Pathologists’ Minimum dataset for breast cancer histopathology. Sheffield/London: NHS Cancer Screening Programmes/Royal College of Pathologists; 2005.

    Google Scholar 

  26. O’Malley FP, Pinder SE, Mulligan AM. Breast pathology. Philadelphia: Elsevier/Saunders; 2011. http://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20090418932.

    Google Scholar 

  27. Van Bogaert LJ, Maldague P. Infiltrating lobular carcinoma of the female breast. Deviations from the usual histopathologic appearance. Cancer. 1980;45(5):979–84.

    Article  PubMed  Google Scholar 

  28. Tavassoli FA, Schnitt SJ. Pathology of the breast. Norwalk Conn: Appleton & Lange; 1992.

    Google Scholar 

  29. Tavassoli FA, Eusebi V, American Registry of P, Armed Forces Institute of P. Tumors of the mammary gland. Washington, D.C.: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2009.

    Google Scholar 

  30. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology. 1982;6(2):149–61.

    Article  CAS  PubMed  Google Scholar 

  31. Frost AR, Tsangaris NT, Silverberg SG. Pleomorphic lobular carcinoma in situ. Pathol Case Rev. 1996;1:27–31.

    Article  Google Scholar 

  32. Rosen PP. Rosen’s breast pathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.

    Google Scholar 

  33. Shin SJ, Lal A, De Vries S, Suzuki J, Roy R, Hwang ES, et al. Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol. 2013;44(10):1998–2009.

    Article  CAS  PubMed  Google Scholar 

  34. Alvarado-Cabrero I, Picon Coronel G, Valencia Cedillo R, Canedo N, Tavassoli FA. Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma. Arch Med Res. 2010;41(6):436–41.

    Article  PubMed  Google Scholar 

  35. Bagaria SP, Shamonki J, Kinnaird M, Ray PS, Giuliano AE. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol. 2011;18(7):1845–51.

    Article  PubMed  Google Scholar 

  36. Anderson JA. Lobular carcinoma in situ. A histological study of 52 cases. Acta Pathol Microbiol Scand Sect Pathol. 1974;82(6):735–41.

    CAS  Google Scholar 

  37. Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78(7):1403–16.

    Article  CAS  PubMed  Google Scholar 

  38. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol. 2001;25(2):229–36.

    Article  CAS  PubMed  Google Scholar 

  39. Liberman L, Sama M, Susnik B, Rosen PP, LaTrenta LR, Morris EA, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173(2):291–9.

    Article  CAS  PubMed  Google Scholar 

  40. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol. 2001;115(1):85–98.

    Article  CAS  PubMed  Google Scholar 

  41. Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000;436(5):421–30.

    Article  CAS  PubMed  Google Scholar 

  42. Hwang H, Barke LD, Mendelson EB, Susnik B. Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol. 2008;21(10):1208–16.

    Article  PubMed  Google Scholar 

  43. Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, et al. Lobular intraepithelial neoplasia lobular carcinoma in situ. with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol. 2006;30(11):1445–53.

    Article  PubMed  Google Scholar 

  44. Boldt V, Stacher E, Halbwedl I, Popper H, Hultschig C, Moinfar F, et al. Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression. Genes Chromosomes Cancer. 2010;49(5):463–70.

    CAS  PubMed  Google Scholar 

  45. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol. 2001;25(2):237–44.

    Article  CAS  PubMed  Google Scholar 

  46. Rosen PP. Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit. Am J Surg Pathol. 1980;4(3):241–6.

    Article  CAS  PubMed  Google Scholar 

  47. Koerner F, Maluf H. Uncommon morphologic patterns of lobular neoplasia. Ann Diagn Pathol. 1999;3(4):249–59.

    Article  CAS  PubMed  Google Scholar 

  48. Hutter RV, Snyder RE, Lucas JC, Foote Jr FW, Farrow JH. Clinical and pathologic correlation with mammographic findings in lobular carcinoma in situ. Cancer. 1969;23(4):826–39.

    Article  CAS  PubMed  Google Scholar 

  49. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001;176(5):1255–9.

    Article  CAS  PubMed  Google Scholar 

  50. D’Alfonso TM, Wang K, Chiu YL, Shin SJ. Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target. Arch Pathol Lab Med. 2013;137(7):927–35.

    Article  PubMed  Google Scholar 

  51. Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 2012;19(10):3131–8.

    Article  PubMed  Google Scholar 

  52. Crisi GM, Mandavilli S, Cronin E, Ricci Jr A. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol. 2003;27(3):325–33.

    Article  PubMed  Google Scholar 

  53. Esserman LE, Lamea L, Tanev S, Poppiti R. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Breast J. 2007;13(1):55–61.

    Article  PubMed  Google Scholar 

  54. Karabakhtsian RG, Johnson R, Sumkin J, Dabbs DJ. The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol. 2007;31(5):717–23.

    Article  PubMed  Google Scholar 

  55. Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol. 2008;32(11):1721–6.

    Article  PubMed  Google Scholar 

  56. Zhang X, Hanamura N, Yamasita M, Kashikura Y, Ogawa T, Taizo S. A case of lobular carcinoma in situ presenting as a solid mass. Br J Radiol. 2011;84(999):e48–50.

    Article  CAS  PubMed  Google Scholar 

  57. Van Goethem M, Schelfout K, Kersschot E, Colpaert C, Verslegers I, Biltjes I, et al. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination. Eur Radiol. 2004;14(8):1363–70.

    PubMed  Google Scholar 

  58. Gomes DS, Porto SS, Balabram D, Gobbi H. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Diagn Pathol. 2014;9:121.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002;15(10):1044–50.

    Article  PubMed  Google Scholar 

  60. Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009;33(11):1683–94.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Haagensen CD. Diseases of the breast. Philadelphia: WB Saunders; 1971.

    Google Scholar 

  62. Zippel HH, Henatsch HJ, Kunze WP. Morphometric and cytophotometric investigations of lobular neoplasia of the breast with ductal involvement. J Cancer Res Clin Oncol. 1979;93(3):265–74.

    Article  CAS  PubMed  Google Scholar 

  63. Chaudhary S, Lawrence L, McGinty G, Kostroff K, Bhuiya T. Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy. Mod Pathol. 2013;26(6):762–71.

    Article  PubMed  Google Scholar 

  64. Choi YJ, Pinto MM, Hao L, Riba AK. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol. 2008;21(10):1224–37.

    Article  CAS  PubMed  Google Scholar 

  65. Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, et al. Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol. 2008;32(5):773–83.

    Article  PubMed  Google Scholar 

  66. Rakha EA, Patel A, Powe DG, Benhasouna A, Green AR, Lambros MB, et al. Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol. 2010;34(10):1472–9.

    Article  PubMed  Google Scholar 

  67. Wells JM, Pipa J, Shin SJ. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol. 2014;38(3):434–5.

    Article  PubMed  Google Scholar 

  68. Shibata T, Kokubu A, Sekine S, Kanai Y, Hirohashi S. Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. Am J Pathol. 2004;164(6):2269–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Sarrio D, Perez-Mies B, Hardisson D, Moreno-Bueno G, Suarez A, Cano A, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene. 2004;23(19):3272–83.

    Article  CAS  PubMed  Google Scholar 

  70. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol. 2002;33(6):620–7.

    Article  CAS  PubMed  Google Scholar 

  71. Green AR, Young P, Krivinskas S, Rakha EA, Claire Paish E, Powe DG, et al. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR. Histopathology. 2009;54(4):419–27.

    Article  PubMed  Google Scholar 

  72. Carder PJ, Shaaban A, Alizadeh Y, Kumarasuwamy V, Liston JC, Sharma N. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology. 2010;57(3):472–8.

    Article  PubMed  Google Scholar 

  73. Khoury T, Karabakhtsian RG, Mattson D, Yan L, Syriac S, Habib F, et al. Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases. Histopathology. 2014;64(7):981–93.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Ross DS, Hoda SA. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases. Am J Surg Pathol. 2011;35(5):750–6.

    Article  PubMed  Google Scholar 

  75. Nemoto T, Castillo N, Tsukada Y, Koul A, Eckhert Jr KH, Bauer RL. Lobular carcinoma in situ with microinvasion. J Surg Oncol. 1998;67(1):41–6.

    Article  CAS  PubMed  Google Scholar 

  76. Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol. 1999;23(12):1561.

    Article  CAS  PubMed  Google Scholar 

  77. Sahoo S, Recant WM. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast. Breast J. 2005;11(2):140–2.

    Article  PubMed  Google Scholar 

  78. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31(3):417–26.

    Article  PubMed  Google Scholar 

  79. Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol. 2008;32(4):513–23.

    Article  PubMed  Google Scholar 

  80. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res. 1998;58(20):4721–7.

    CAS  PubMed  Google Scholar 

  81. Buerger H, Simon R, Schafer KL, Diallo R, Littmann R, Poremba C, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol. 2000;53(3):118–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung BM, et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol. 2001;32(3):292–6.

    Article  CAS  PubMed  Google Scholar 

  83. Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004;100(12):2562–72.

    Article  PubMed  Google Scholar 

  84. Mastracci TL, Shadeo A, Colby SM, Tuck AB, O’Malley FP, Bull SB, et al. Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosomes Cancer. 2006;45(11):1007–17.

    Article  CAS  PubMed  Google Scholar 

  85. Morandi L, Marucci G, Foschini MP, Cattani MG, Pession A, Riva C, et al. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch. 2006;449(1):14–23.

    Article  PubMed  Google Scholar 

  86. Andrade VP, Ostrovnaya I, Seshan VE, Morrogh M, Giri D, Olvera N, et al. Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions. Breast Cancer Res. 2012;14(4):R103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999;59(7):1433–6.

    CAS  PubMed  Google Scholar 

  88. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol. 1999;187(4):396–402.

    Article  CAS  PubMed  Google Scholar 

  89. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer. 1997;74(5):513–7.

    Article  CAS  PubMed  Google Scholar 

  90. Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat. 2008;107(3):331–5.

    Article  PubMed  Google Scholar 

  91. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch. 2002;440(2):134–8.

    Article  PubMed  Google Scholar 

  92. Gomes DS, Balabram D, Porto SS, Gobbi H. Lobular neoplasia: frequency and association with other breast lesions. Diagn Pathol. 2011;6:74.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol. 2005;207(1):1–13.

    Article  CAS  PubMed  Google Scholar 

  94. Subhawong AP, Subhawong TK, Khouri N, Tsangaris T, Nassar H. Incidental minimal atypical lobular hyperplasia on core needle biopsy: correlation with findings on follow-up excision. Am J Surg Pathol. 2010;34(6):822–8.

    Article  PubMed  Google Scholar 

  95. Polom K, Murawa D, Pawelska A, Murawa P. Atypical lobular hyperplasia and lobular carcinoma in situ without other high-risk lesions diagnosed on vacuum-assisted core needle biopsy. The problem of excisional biopsy. Tumori. 2009;95(1):32–5.

    PubMed  Google Scholar 

  96. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29(4):534–43.

    Article  PubMed  Google Scholar 

  97. Nagi CS, O’Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM. Lobular neoplasia on core needle biopsy does not require excision. Cancer. 2008;112(10):2152–8.

    Article  PubMed  Google Scholar 

  98. Atkins KA, Cohen MA, Nicholson B, Rao S. Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation. Radiology. 2013;269(2):340–7.

    Article  PubMed  Google Scholar 

  99. Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer. 2013;119(5):1073–9.

    Article  PubMed  Google Scholar 

  100. Rendi MH, Dintzis SM, Lehman CD, Calhoun KE, Allison KH. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 2012;19(3):914–21.

    Article  PubMed  Google Scholar 

  101. Bianchi S, Bendinelli B, Castellano I, Piubello Q, Renne G, Cattani MG, et al. Morphological parameters of lobular in situ neoplasia in stereotactic 11-gauge vacuum-assisted needle core biopsy do not predict the presence of malignancy on subsequent surgical excision. Histopathology. 2013;63(1):83–95.

    Article  PubMed  Google Scholar 

  102. Brem RF, Lechner MC, Jackman RJ, Rapelyea JA, Evans WP, Philpotts LE, et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol. 2008;190(3):637–41.

    Article  PubMed  Google Scholar 

  103. Lewis JL, Lee DY, Tartter PI. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol. 2012;19(13):4124–8.

    Article  PubMed  Google Scholar 

  104. Zhao C, Desouki MM, Florea A, Mohammed K, Li X, Dabbs D. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 2012;138(1):72–8.

    Article  PubMed  Google Scholar 

  105. Renshaw AA, Derhagopian RP, Martinez P, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol. 2006;126(2):310–3.

    Article  PubMed  Google Scholar 

  106. Middleton LP, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P, et al. Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med. 2014;3(3):492–9.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwif K, Hwang ES, et al. Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020). Ann Surg Oncol. 2016;23(3):722–8.

    Google Scholar 

  108. Susnik B, Day D, Krueger J, Abeln E, Bowman T, Lillemoe TJ. Surgical outcome of lobular neoplasia diagnosed on core biopsy: prospective study of 316 cases. In: 2014 breast cancer symposium, September 4–6, San Francisco, CA, 2014.

    Google Scholar 

  109. Sullivan ME, Khan SA, Sullu Y, Schiller C, Susnik B. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 2010;134(7):1024–8.

    PubMed  Google Scholar 

  110. Lavoue V, Graesslin O, Classe JM, Fondrinier E, Angibeau H, Leveque J. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast (Edinburgh, Scotland). 2007;16(5):533–9.

    Google Scholar 

  111. McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, et al. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer. 2006;107(6):1227–33.

    Article  PubMed  Google Scholar 

  112. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer. 1996;78(5):1024–34.

    Article  CAS  PubMed  Google Scholar 

  113. Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23(24):5534–41.

    Article  PubMed  Google Scholar 

  114. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.

    Article  CAS  PubMed  Google Scholar 

  115. Page DL, Dupont WD, Rogers LW. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol. 1988;19(2):201–7.

    Article  CAS  PubMed  Google Scholar 

  116. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer Jr WD, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361(9352):125–9.

    Article  PubMed  Google Scholar 

  117. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267(7):941–4.

    Article  CAS  PubMed  Google Scholar 

  118. Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997;6(5):297–301.

    CAS  PubMed  Google Scholar 

  119. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer. 2007;109(2):180–7.

    Article  PubMed  Google Scholar 

  120. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229–37.

    Article  CAS  PubMed  Google Scholar 

  121. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25(19):2671–7.

    Article  PubMed  Google Scholar 

  122. Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res. 2014;7(2):211–7.

    Article  CAS  Google Scholar 

  123. Haagensen CD. Diseases of the breast. Philadelphia: Saunders; 1986.

    Google Scholar 

  124. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer. 1993;71(12):3896–907.

    Article  CAS  PubMed  Google Scholar 

  125. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100(2):238–44.

    Article  PubMed  Google Scholar 

  126. Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer. 2006;106(10):2104–12.

    Article  PubMed  Google Scholar 

  127. Benfield JR, Fingerhut AG, Warner NE. Lobular carcinoma of the breast-1969. A therapeutic proposal. Arch Surg. 1969;99(2):129–40.

    Article  CAS  PubMed  Google Scholar 

  128. Andersen JA. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer. 1977;39(6):2597–602.

    Article  CAS  PubMed  Google Scholar 

  129. Ben-David MA, Kleer CG, Paramagul C, Griffith KA, Pierce LJ. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis. Cancer. 2006;106(1):28–34.

    Article  PubMed  Google Scholar 

  130. Ciocca RM, Li T, Freedman GM, Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol. 2008;15(8):2263–71.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Sadek BT, Shenouda MN, Abi Raad RF, Niemierko A, Keruakous AR, Goldberg SI, et al. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary? Int J Radiat Oncol Biol Phys. 2013;87(4):726–30.

    Article  PubMed  Google Scholar 

  132. Cutuli B, Jaeck D, Renaud R, Rodier JF. Lobular carcinoma in situ of the breast: results of a radiosurgical conservative treatment. Oncol Rep. 1998;5(6):1531–3.

    CAS  PubMed  Google Scholar 

  133. Cutuli B, de Lafontan B, Quetin P, Mery E. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ? Eur J Cancer. 2005;41(3):380–5.

    Article  PubMed  Google Scholar 

  134. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90(18):1371–88.

    Article  CAS  PubMed  Google Scholar 

  135. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295(23):2727–41.

    Article  CAS  PubMed  Google Scholar 

  136. Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 2011;364(25):2381–91.

    Article  CAS  PubMed  Google Scholar 

  137. Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012;136(3):627–33.

    Article  CAS  PubMed  Google Scholar 

  138. Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med. 2011;135(6):737–43.

    PubMed  Google Scholar 

  139. Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH. Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management. Ann Surg Oncol. 2015;22(13):4263–9.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Pieri A, Harvey J, Bundred N. Pleomorphic lobular carcinoma in situ of the breast: can the evidence guide practice? World J Clin Oncol. 2014;5(3):546–53.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, UT Southwestern Medical Center, Dallas, TX, 75390, USA

    Helena Hwang M.D. & Sunati Sahoo M.D.

Authors
  1. Helena Hwang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunati Sahoo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helena Hwang M.D. .

Editor information

Editors and Affiliations

  1. New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA

    Sandra J. Shin

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hwang, H., Sahoo, S. (2016). Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ. In: Shin, S. (eds) A Comprehensive Guide to Core Needle Biopsies of the Breast . Springer, Cham. https://doi.org/10.1007/978-3-319-26291-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26291-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26289-5

  • Online ISBN: 978-3-319-26291-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation